Old Second Bancorp, Inc. (OSBC)
NASDAQ: OSBC · Real-Time Price · USD
17.00
-0.28 (-1.62%)
Jul 31, 2025, 1:26 PM - Market open
Longboard Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts that cover Longboard Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $20.08, which forecasts a 18.12% increase in the stock price over the next year. The lowest target is $17 and the highest is $24.5.
Price Target: $20.08 (+18.12%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Longboard Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DA Davidson | DA Davidson | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | +11.76% | Jul 25, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $22 → $25 | Buy | Reiterates | $22 → $25 | +44.12% | Jul 2, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $22 → $20 | Buy | Maintains | $22 → $20 | +17.65% | Apr 25, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +29.41% | Apr 25, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Buy Maintains $22 → $24 | Buy | Maintains | $22 → $24 | +41.18% | Feb 27, 2025 |
Financial Forecast
Revenue This Year
330.09M
from 271.80M
Increased by 21.45%
Revenue Next Year
371.06M
from 330.09M
Increased by 12.41%
EPS This Year
1.81
from 1.87
Decreased by -3.45%
EPS Next Year
2.12
from 1.81
Increased by 17.18%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 348.2M | 386.9M |
| Avg | 330.1M | 371.1M |
| Low | 306.5M | 348.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 28.1% | 17.2% |
| Avg | 21.4% | 12.4% |
| Low | 12.7% | 5.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 2.15 | 2.26 |
| Avg | 1.81 | 2.12 |
| Low | 1.33 | 1.95 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 15.1% | 25.0% |
| Avg | -3.5% | 17.2% |
| Low | -28.7% | 8.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.